Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial
Shoji Nagao(Saitama Medical University), Takayuki Enomoto(Niigata University), Karen K. L. Chan(Queen Mary Hospital), Wong Wai Loong(KK Women's and Children's Hospital), Takeshi Hirasawa(Tokai University), Keiichi Fujiwara(Saitama Medical University), Hiroshi Tanabe(Jikei University Kashiwa hospital), Sosuke Adachi(Niigata University), Kazuhiro Takehara(Shikoku Cancer Center), Motoaki Saito(Jikei University School of Medicine), Peter Syks(University of Otago), Tomonori Nagai(Social Insurance Saitama Chuo Hospital), Shoji Kamiura(Osaka International Cancer Institute), David S.P. Tan(National University of Singapore), Aikou Okamoto(Jikei University School of Medicine), Takeshi Yokoi(Takarazuka City Hospital), Eiji Kondo(Mie University), Alexsander Olawaye(Magee-Womens Hospital), Kosei Hasegawa(Saitama Medical University), Akira Fujishita(Nagasaki Ajisai Hospital), Sang‐Young Ryu, Satoshi Yamaguchi(Hyogo Prefectural Cancer Center), Kouji Yamamoto(Yokohama City University), Hiroyuki Fujiwara(Jichi Medical University), Akira Kikuchi(Niigata Cancer Center Hospital), Toyomi Sato(University of Tsukuba), Takashi Matsumoto(Ehime University), Hiroyuki Shigeta(Yokohama Municipal Citizen's Hospital), Yoshihito Yokoyama(Hirosaki University)
Cited by 31
Related Papers
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
|The Lancet Oncology|2021|401
Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|381
Genome-wide association meta-analysis identifies new endometriosis risk loci
|Nature Genetics|2012|310
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277
Confidence interval for micro-averaged F1 and macro-averaged F1 scores
|Applied Intelligence|2021|273